Cargando…

Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Miyamae, Takako, Nozawa, Tomo, Kikuchi, Masako, Kizawa, Toshitaka, Imagawa, Tomoyuki, Yokota, Shumpei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194481/ http://dx.doi.org/10.1186/1546-0096-9-S1-P130

Ejemplares similares

Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
por: Hara, Ryoki, et al.
Publicado: (2011)

IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
por: Yokota, S, et al.
Publicado: (2003)

PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis
por: Hisa, Kaori, et al.
Publicado: (2017)

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
por: Yokota, S, et al.
Publicado: (2008)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
por: De Benedetti, Fabrizio, et al.
Publicado: (2014)

PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
por: Yokota, S, et al.
Publicado: (2013)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Efficacy of thalidomide for a girl with inflammatory calicinosis, a severe complication of juvenile dermatomyosistis
por: Miyamae, T, et al.
Publicado: (2008)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
por: Goran, Ristic, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
por: Kaleda, Maria I, et al.
Publicado: (2014)

Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis
por: Miyamae, Takako, et al.
Publicado: (2010)

Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy
por: Miyamae, Takako, et al.
Publicado: (2005)

Analysis of Gender Differences in Genetic Risk: Association of TNFAIP3 Polymorphism with Male Childhood-Onset Systemic Lupus Erythematosus in the Japanese Population
por: Kadota, Keisuke, et al.
Publicado: (2013)

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)
por: Yamaguchi, Ken-ichi, et al.
Publicado: (2012)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
por: De Benedetti, F, et al.
Publicado: (2011)

PReS-FINAL-2041: Macrophage activation syndrome in the children with systemic juvenile idiopathic arthritis during the course of tocilizumab
por: Alekseeva, E, et al.
Publicado: (2013)

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
por: Hara, Ryoki, et al.
Publicado: (2019)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
por: Mori, Masaaki, et al.
Publicado: (2008)

Impact of biologics on growth in children with juvenile idiopathic arthritis
por: Uettwiller, F, et al.
Publicado: (2011)

PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
por: De Benedetti, F, et al.
Publicado: (2013)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

Juvenile idiopathic arthritis: the transition to adulthood
por: Fernandes, Susana, et al.
Publicado: (2014)

Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
por: Nikishina, I, et al.
Publicado: (2008)

Clinical and articular presentation of juvenile idiopathic arthritis
por: Ravichandran, R, et al.
Publicado: (2008)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Depression, anxiety and pain in juvenile idiopathic arthritis
por: Erdogdu, D, et al.
Publicado: (2008)

Illness representation in adolescents with juvenile idiopathic arthritis
por: Lelieveld, OTHM, et al.
Publicado: (2008)

Systemic juvenile idiopathic arthritis in the republic of Bashkortostan
por: Malievskiy, VA
Publicado: (2011)

Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis
por: Schou, AJ, et al.
Publicado: (2011)

TH17-phenotypes of juvenile idiopathic arthritis
por: Turtsevich, Inga Z, et al.
Publicado: (2014)

Methotrexate in oligoarticular persistent juvenile idiopathic arthritis
por: Horneff, Gerd, et al.
Publicado: (2014)

Juvenile idiopathic arthritis is a diagnosis of exclusion
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Juvenile idiopathic arthritis treated with biological therapies
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami, Miho, et al.
Publicado: (2012)

Fever without apparent sources in children: a nation-wide study in Japan
por: Kasai, K, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_pp1mqpbcuqi6o9ofbangeecmg4